SINOMED(688108.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
SINOMED
688108.SH
Sino Medical Sciences Technology Inc., a medical device company, engages in the research, development, production, and distribution of interventional medical devices in China. Its products include coronary drug stents, coronary balloons catheter, intracranial rapid exchange balloons, and intracranial drug-eluting stents, as well as transapical mitral valve replacement system. Sino Medical Sciences Technology Inc. was incorporated in 2007 and is headquartered in Tianjin, China.
871.65 B
688108.SHMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
B
Health Care EquipmentIndustry
Industry Ranking15/64
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE7.39%B
    • Profit Margin12.19%B
    • Gross Margin69.81%A
  • Growth ScoreB
    • Revenue YoY20.44%B
    • Net Profit YoY1020.20%A
    • Total Assets YoY3.29%C
    • Net Assets YoY18.01%A
  • Cash ScoreA
    • Cash Flow Margin266.85%A
    • OCF YoY20.44%B
  • Operating ScoreC
    • Turnover0.43C
  • Debt ScoreA
    • Gearing Ratio19.84%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    07:13 ETThe EXCEL - First-of-its-kind study highlights critical role of essential phospholipids in improving Fatty Liver Disease

    prnewswire·
    US
    SNY
    +0.02%
    US
    IBB
    +0.10%
    US
    LABU
    -2.35%
    prnewswire·
    US
    SNY
    +0.02%
    US
    IBB
    +0.10%
    US
    LABU
    -2.35%

    Sanofi's Lunsekimig Shows Promise In Respiratory Diseases

    nasdaq·
    US
    ARKG
    +0.04%
    SZ
    159837
    -0.22%
    SZ
    159849
    -0.21%
    nasdaq·
    US
    ARKG
    +0.04%
    SZ
    159837
    -0.22%
    SZ
    159849
    -0.21%

    Sanofi: European Commission Grants Conditional Marketing Authorisation For Rezurock

    rttnews·
    US
    IXJ
    +0.79%
    US
    XLV
    +1.10%
    SH
    513060
    -0.38%
    rttnews·
    US
    IXJ
    +0.79%
    US
    XLV
    +1.10%
    SH
    513060
    -0.38%

    SINOMED: Planning to issue H-shares and list on The Stock Exchange of Hong Kong Limited

    Wallstreetcn·
    SH
    688108
    -3.30%
    Wallstreetcn·
    SH
    688108
    -3.30%

    Key facts: Dupixent Japan approval; Sarclisa CHMP nod; IL‑33 COPD fails

    TradingView·
    US
    LABU
    -2.35%
    SH
    688108
    -3.30%
    SZ
    159892
    -0.71%
    TradingView·
    US
    LABU
    -2.35%
    SH
    688108
    -3.30%
    SZ
    159892
    -0.71%
    © 2026 Longbridge｜Disclaimer